COVIDomics: The proteomic and metabolomic signatures of COVID-19

M Costanzo, M Caterino, R Fedele, A Cevenini… - International journal of …, 2022 - mdpi.com
Omics-based technologies have been largely adopted during this unprecedented global
COVID-19 pandemic, allowing the scientific community to perform research on a large scale …

Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease

CA Labarrere, GS Kassab - Frontiers in Microbiology, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus
disease 19 (COVID-19) has numerous risk factors leading to severe disease with high …

Multi-omics for COVID-19: driving development of therapeutics and vaccines

M Guo, M Xiong, J Peng, T Guan, H Su… - National Science …, 2023 - academic.oup.com
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised global concern for
public health and economy. The development of therapeutics and vaccines to combat this …

Genomic communication via circulating extracellular vesicles and long-term health consequences of COVID-19

S Nair, E Nova-Lamperti, G Labarca… - Journal of Translational …, 2023 - Springer
COVID-19 continues to affect an unprecedented number of people with the emergence of
new variants posing a serious challenge to global health. There is an expansion of …

Development trends of human organoid‐based COVID‐19 research based on bibliometric analysis

M Li, Y Yuan, T Zou, Z Hou, L Jin, B Wang - Cell Proliferation, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), a global pandemic caused by the severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has posed a catastrophic threat …

Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis

H Meng, A Sengupta, E Ricciotti… - Clinical and …, 2023 - Wiley Online Library
Background Lipids may influence cellular penetrance by viral pathogens and the immune
response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 …

New discovery of myeloid-derived suppressor cell's tale on viral infection and COVID-19

SJ Park, D Nam, HC Seong, YS Hahn - Frontiers in Immunology, 2022 - frontiersin.org
Myeloid-derived suppressor cells (MDSCs) are generated under biological stress such as
cancer, inflammatory tissue damage, and viral infection. In recent years, with occurrence of …

New Insights into the Identification of Metabolites and Cytokines Predictive of Outcome for Patients with Severe SARS-CoV-2 Infection Showed Similarity with Cancer

S Costantini, G Madonna, E Di Gennaro… - International Journal of …, 2023 - mdpi.com
SARS-CoV-2 infection is characterized by several clinical manifestations, ranging from the
absence of symptoms to severe forms that necessitate intensive care treatment. It is known …

Pathogenic mechanism and multi-omics analysis of oral manifestations in COVID-19

M Hao, D Wang, Q Xia, S Kan, L Chang, H Liu… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is a respiratory infectious disease that seriously
threatens human life. The clinical manifestations of severe COVID-19 include acute …

Bioinformatics and molecular biology tools for diagnosis, prevention, treatment and prognosis of COVID-19

DD Meira, ASS Zetum, MC Casotti, DRC da Silva… - Heliyon, 2024 - cell.com
Since December 2019, a new form of Severe Acute Respiratory Syndrome (SARS) has
emerged worldwide, caused by SARS coronavirus 2 (SARS-CoV-2). This disease was …